Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS‐MI): rationale and design
Article in ESC Heart Failure (May 2024)
The most recent citing publications are shown below. View all 418 publications that cite this research output on Dimensions.
Article in ESC Heart Failure (May 2024)
Article in Journal of Magnetic Resonance Imaging (April 2024)
Article in The International Journal of Cardiovascular Imaging (April 2024)